Results 131 to 140 of about 68,366 (207)

SIRI, SII, and PNI in psychiatric patients with positive urinary drug metabolites: association with immune and nutritional biomarkers. [PDF]

BMC Psychiatry
Yildiz A, Karabiyik B, Deniz L.
europepmc   +1 more source

Refining drug screening with automated home cage monitoring: a crossover study in socially housed rats. [PDF]

Front Toxicol
Connor DA, Nifong B, Payseur JD, Wu X, Rossman EI, Koshy Cherian A.   +5 more
europepmc   +1 more source

Centanafadine (Simtriyo®): a first-in-class triple reuptake inhibitor approved for attention-deficit/hyperactivity disorder (ADHD). [PDF]

Med Chem Res
Hu L.
europepmc   +1 more source

Network Pharmacology Reveals the Potential Mechanism of Ketamine in Improving Cognitive Impairment in Patients With Depression. [PDF]

Alpha Psychiatry
Yang L, Zhang Q, Zhang Y, Yao K, Chen X, Tian H, Zhuo C.   +6 more
europepmc   +1 more source

Optimal buprenorphine exposure to treat patients with opioid use disorder in the era of fentanyl and polysubstance use. [PDF]

Front Pharmacol
Lohmer LRL, Greenwald MK, Kakar R, Laffont CM.   +3 more
europepmc   +1 more source

Maintained Symptom Control Following a Shortage-Driven Switch to Immediate-Release Dextroamphetamine: A Case Report. [PDF]

Cureus
Singer D, Kothari PM.
europepmc   +1 more source

Contributions of the interaction between mu-opioid receptors and dopamine receptors in the regulation of risky decision making. [PDF]

Prog Neuropsychopharmacol Biol Psychiatry
Kahanek P, Opachich Z, Csitkovits I, Kelly M, Orsini CA.   +4 more
europepmc   +1 more source